ArticleNational science review2018
On the low reproducibility of cancer studies.
Article in National science review, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- Nanomaterials for the Prevention, Detection, and Treatment of Pharyngeal Human Papillomavirus Infection: A Translational Roadmap.Materials (Basel, Switzerland) · 2026Review
- From ideal to practical: Heterogeneity of student-generated variant lists highlights hidden reproducibility gaps.PLoS computational biology · 2025Article
- Redefining cancer research for therapeutic breakthroughs.British journal of cancer · 2024Review
- Advances towards the use of gastrointestinal tumor patient-derived organoids as a therapeutic decision-making tool.Biological research · 2023Review
- Very large hidden genetic diversity in one single tumor: evidence for tumors-in-tumor.National science review · 2022Article
- Two decades of suspect evidence for adaptive molecular evolution-negative selection confounding positive-selection signals.National science review · 2022Article
- Article
- Antinociceptive Effects of Kappa-Opioid Receptor Agonists.Handbook of experimental pharmacology · 2022Review
- Meta-analysis on reporting practices as a source of heterogeneity in in vitro cancer research.BMJ open science · 2022Article
- Computational systems-biology approaches for modeling gene networks driving epithelial-mesenchymal transitions.Computational and systems oncology · 2021Article
- Variation in the life history strategy underlies functional diversity of tumors.National science review · 2021Article
- NPARS-A Novel Approach to Address Accuracy and Reproducibility in Genomic Data Science.Frontiers in big data · 2021Article
- Reducing sources of variance in experimental procedures in in vitro research.F1000Research · 2021Article
- Heightened protein-translation activities in mammalian cells and the disease/treatment implications.National science review · 2020Article
- The origin and underlying driving forces of the SARS-CoV-2 outbreak.Journal of biomedical science · 2020Article
- Convergent adaptive evolution-how common, or how rare?National science review · 2020Article
- Adaptive convergence at the genomic level-prevalent, uncommon or very rare?National science review · 2020Article
- Inadequate Reporting of Analytical Characteristics of Biomarkers Used in Clinical Research: A Threat to Interpretation and Replication of Study Findings.Clinical chemistry · 2019Article
- Gene regulatory network stabilized by pervasive weak repressions: microRNA functions revealed by the May-Wigner theory.National science review · 2019Article
- Molecular Evolution in Small Steps under Prevailing Negative Selection: A Nearly Universal Rule of Codon Substitution.Genome biology and evolution · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.